Arctic Bioscience AS banner
A

Arctic Bioscience AS
OSE:ABS

Watchlist Manager
Arctic Bioscience AS
OSE:ABS
Watchlist
Price: 3.37 NOK -2.03% Market Closed
Market Cap: kr90.9m

Arctic Bioscience AS
Net Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Arctic Bioscience AS
Net Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
A
Arctic Bioscience AS
OSE:ABS
Net Income
-kr47.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
Net Income
-kr94.3m
CAGR 3-Years
-25%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Net Income
kr12.2m
CAGR 3-Years
-34%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
N
Nykode Therapeutics ASA
OSE:NYKD
Net Income
-$17.7m
CAGR 3-Years
30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Circio Holding ASA
OSE:CRNA
Net Income
-kr9.2m
CAGR 3-Years
56%
CAGR 5-Years
40%
CAGR 10-Years
12%
T
Thor Medical ASA
OSE:TRMED
Net Income
-kr62.3m
CAGR 3-Years
48%
CAGR 5-Years
32%
CAGR 10-Years
0%
No Stocks Found

Arctic Bioscience AS
Glance View

Market Cap
90.9m NOK
Industry
Biotechnology

Arctic Bioscience AS engages in the development, manufacturing, and marketing of marine ingredients extracted from herring roe. The company is headquartered in Orsta, More Og Romsdal. The company went IPO on 2021-02-24. Arctic Bioscience’s purpose is to provide people with autoimmune disorders an effective and healthy therapy based on marine membrane lipids. The firm is developing HRO350 - a novel investigational drug candidate. HRO350 is being developed for treatment of patients with mild-to-moderate psoriasis. The firm's product portfolio includes, among others, Romega, which is a producer of an omega-3 dietary supplement made from herring roe in a form of a capsule, as well as herring caviar oil and herring caviar protein offered to Business-to-Business (B2B) customers. Arctic Bioscience AS has three subsidiaries Arctic Nutrition AS, Romega AS and Arctic Biopharma AS.

ABS Intrinsic Value
7.41 NOK
Undervaluation 55%
Intrinsic Value
Price kr3.37
A

See Also

What is Arctic Bioscience AS's Net Income?
Net Income
-47.9m NOK

Based on the financial report for Dec 31, 2024, Arctic Bioscience AS's Net Income amounts to -47.9m NOK.

What is Arctic Bioscience AS's Net Income growth rate?
Net Income CAGR 1Y
-5%

Over the last year, the Net Income growth was -5%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett